 Kia Washington
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye | 5 | 2025 | 112 | 2.640 |
Why?
| | Facial Transplantation | 4 | 2022 | 10 | 1.450 |
Why?
| | Blindness | 3 | 2016 | 51 | 1.410 |
Why?
| | Vascularized Composite Allotransplantation | 4 | 2024 | 30 | 1.350 |
Why?
| | Tacrolimus | 5 | 2024 | 196 | 1.260 |
Why?
| | Retina | 2 | 2024 | 326 | 1.090 |
Why?
| | Graft Rejection | 7 | 2025 | 521 | 1.060 |
Why?
| | Vibrissae | 3 | 2022 | 11 | 0.950 |
Why?
| | Corneal Transplantation | 1 | 2025 | 17 | 0.870 |
Why?
| | Rats | 17 | 2025 | 5584 | 0.800 |
Why?
| | Stem Cell Transplantation | 1 | 2024 | 189 | 0.760 |
Why?
| | Myelin Sheath | 2 | 2024 | 166 | 0.730 |
Why?
| | Nerve Regeneration | 6 | 2024 | 58 | 0.690 |
Why?
| | Optic Nerve Injuries | 2 | 2017 | 9 | 0.630 |
Why?
| | Tissue and Organ Harvesting | 2 | 2016 | 78 | 0.590 |
Why?
| | Peripheral Nerve Injuries | 2 | 2018 | 38 | 0.490 |
Why?
| | Transplantation, Homologous | 6 | 2020 | 418 | 0.470 |
Why?
| | Organ Transplantation | 2 | 2016 | 251 | 0.470 |
Why?
| | Somatosensory Cortex | 2 | 2022 | 42 | 0.460 |
Why?
| | Neurons, Afferent | 1 | 2016 | 102 | 0.450 |
Why?
| | Animals | 24 | 2025 | 38030 | 0.420 |
Why?
| | Composite Tissue Allografts | 2 | 2022 | 8 | 0.370 |
Why?
| | Rectus Abdominis | 2 | 2024 | 16 | 0.370 |
Why?
| | Adaptation, Physiological | 1 | 2016 | 560 | 0.350 |
Why?
| | Retinal Ganglion Cells | 2 | 2024 | 121 | 0.320 |
Why?
| | Models, Animal | 3 | 2025 | 393 | 0.300 |
Why?
| | Hindlimb | 5 | 2023 | 132 | 0.300 |
Why?
| | Tissue Transplantation | 1 | 2009 | 10 | 0.290 |
Why?
| | Surgery, Plastic | 2 | 2020 | 53 | 0.290 |
Why?
| | Craniofacial Abnormalities | 1 | 2009 | 78 | 0.280 |
Why?
| | Neurons | 3 | 2024 | 1649 | 0.230 |
Why?
| | Electroretinography | 1 | 2025 | 50 | 0.220 |
Why?
| | Organ Preservation Solutions | 1 | 2024 | 46 | 0.210 |
Why?
| | Myocutaneous Flap | 1 | 2024 | 8 | 0.210 |
Why?
| | Transplantation Immunology | 1 | 2024 | 29 | 0.210 |
Why?
| | Iliac Artery | 1 | 2024 | 55 | 0.210 |
Why?
| | Urethane | 1 | 2024 | 43 | 0.200 |
Why?
| | Immunotoxins | 1 | 2024 | 55 | 0.200 |
Why?
| | Organ Preservation | 1 | 2024 | 125 | 0.200 |
Why?
| | Carbamates | 1 | 2024 | 50 | 0.200 |
Why?
| | Esters | 1 | 2024 | 71 | 0.200 |
Why?
| | Costal Cartilage | 1 | 2023 | 2 | 0.200 |
Why?
| | Urea | 1 | 2024 | 85 | 0.200 |
Why?
| | Facial Hemiatrophy | 1 | 2023 | 2 | 0.200 |
Why?
| | Amides | 1 | 2024 | 101 | 0.190 |
Why?
| | Retinal Diseases | 1 | 2024 | 101 | 0.190 |
Why?
| | Tissue Scaffolds | 2 | 2023 | 221 | 0.190 |
Why?
| | Tomography, Optical Coherence | 1 | 2025 | 271 | 0.190 |
Why?
| | Adenosine | 1 | 2024 | 255 | 0.190 |
Why?
| | Physical Stimulation | 1 | 2022 | 68 | 0.190 |
Why?
| | Swine | 5 | 2024 | 825 | 0.180 |
Why?
| | Free Tissue Flaps | 1 | 2023 | 54 | 0.180 |
Why?
| | Manganese | 1 | 2022 | 55 | 0.180 |
Why?
| | Rats, Inbred Lew | 6 | 2023 | 105 | 0.170 |
Why?
| | Visual Pathways | 1 | 2022 | 61 | 0.170 |
Why?
| | Skin Transplantation | 2 | 2014 | 85 | 0.170 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4560 | 0.170 |
Why?
| | Thalamus | 1 | 2022 | 129 | 0.170 |
Why?
| | Immunosuppressive Agents | 5 | 2023 | 838 | 0.170 |
Why?
| | Surgical Flaps | 2 | 2014 | 142 | 0.160 |
Why?
| | Graft Survival | 4 | 2024 | 518 | 0.160 |
Why?
| | Rats, Inbred BN | 5 | 2023 | 56 | 0.160 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2020 | 17 | 0.160 |
Why?
| | Cytokines | 2 | 2025 | 2067 | 0.150 |
Why?
| | Parental Leave | 1 | 2019 | 27 | 0.150 |
Why?
| | Sexism | 1 | 2020 | 68 | 0.150 |
Why?
| | Family Planning Services | 1 | 2019 | 93 | 0.140 |
Why?
| | Physicians, Women | 1 | 2019 | 89 | 0.140 |
Why?
| | Swine, Miniature | 3 | 2024 | 89 | 0.130 |
Why?
| | Peripheral Nerves | 1 | 2018 | 72 | 0.130 |
Why?
| | Career Choice | 1 | 2019 | 234 | 0.130 |
Why?
| | Tissue Survival | 1 | 2016 | 16 | 0.130 |
Why?
| | Recovery of Function | 2 | 2013 | 716 | 0.120 |
Why?
| | Refractory Period, Electrophysiological | 1 | 2016 | 5 | 0.120 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2016 | 39 | 0.120 |
Why?
| | Beneficence | 1 | 2016 | 20 | 0.120 |
Why?
| | Hydrogels | 1 | 2023 | 701 | 0.120 |
Why?
| | Trigeminal Ganglion | 1 | 2016 | 27 | 0.120 |
Why?
| | Lymphoproliferative Disorders | 1 | 2016 | 57 | 0.110 |
Why?
| | Leadership | 1 | 2020 | 401 | 0.110 |
Why?
| | Biomarkers | 2 | 2025 | 4295 | 0.110 |
Why?
| | Central Nervous System | 1 | 2017 | 282 | 0.110 |
Why?
| | Surgeons | 1 | 2020 | 340 | 0.110 |
Why?
| | Social Justice | 1 | 2016 | 81 | 0.110 |
Why?
| | Cervicoplasty | 1 | 2014 | 1 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3904 | 0.110 |
Why?
| | Neck Injuries | 1 | 2014 | 21 | 0.110 |
Why?
| | Postoperative Care | 1 | 2016 | 286 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 562 | 0.100 |
Why?
| | Reaction Time | 1 | 2016 | 433 | 0.100 |
Why?
| | Extracellular Matrix | 1 | 2018 | 562 | 0.100 |
Why?
| | Insulin | 1 | 2024 | 2512 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5983 | 0.100 |
Why?
| | Transplantation, Isogeneic | 2 | 2009 | 17 | 0.090 |
Why?
| | Humans | 12 | 2024 | 145474 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 2214 | 0.090 |
Why?
| | Male | 9 | 2025 | 72842 | 0.090 |
Why?
| | Tissue and Organ Procurement | 1 | 2016 | 343 | 0.090 |
Why?
| | Patient Selection | 1 | 2016 | 738 | 0.090 |
Why?
| | Feasibility Studies | 1 | 2016 | 1111 | 0.090 |
Why?
| | Allografts | 2 | 2023 | 152 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2524 | 0.080 |
Why?
| | Immune Tolerance | 2 | 2009 | 385 | 0.080 |
Why?
| | Burns | 1 | 2014 | 374 | 0.070 |
Why?
| | Facial Asymmetry | 1 | 2009 | 4 | 0.070 |
Why?
| | Mandibulofacial Dysostosis | 1 | 2009 | 5 | 0.070 |
Why?
| | Cyclosporine | 4 | 2013 | 256 | 0.070 |
Why?
| | Isoantibodies | 1 | 2009 | 57 | 0.070 |
Why?
| | Nose | 1 | 2009 | 67 | 0.070 |
Why?
| | Cleft Lip | 1 | 2009 | 73 | 0.070 |
Why?
| | Age Factors | 1 | 2016 | 3342 | 0.070 |
Why?
| | Craniosynostoses | 1 | 2009 | 69 | 0.070 |
Why?
| | Cleft Palate | 1 | 2009 | 91 | 0.070 |
Why?
| | Face | 1 | 2009 | 174 | 0.060 |
Why?
| | Raffinose | 1 | 2024 | 29 | 0.050 |
Why?
| | Allopurinol | 1 | 2024 | 70 | 0.050 |
Why?
| | Receptors, CCR4 | 1 | 2024 | 24 | 0.050 |
Why?
| | Cryopreservation | 1 | 2024 | 113 | 0.050 |
Why?
| | Fascia | 1 | 2023 | 19 | 0.050 |
Why?
| | Mice, SCID | 1 | 2024 | 369 | 0.050 |
Why?
| | Glutathione | 1 | 2024 | 370 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2024 | 440 | 0.050 |
Why?
| | Atrophy | 1 | 2023 | 199 | 0.050 |
Why?
| | Abatacept | 1 | 2022 | 56 | 0.050 |
Why?
| | Rabbits | 1 | 2023 | 652 | 0.040 |
Why?
| | Optic Nerve | 1 | 2022 | 67 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 574 | 0.040 |
Why?
| | Sirolimus | 1 | 2022 | 280 | 0.040 |
Why?
| | Transplantation, Heterotopic | 1 | 2020 | 16 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 450 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 286 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2906 | 0.040 |
Why?
| | Macaca | 1 | 2020 | 66 | 0.040 |
Why?
| | Schwann Cells | 1 | 2020 | 33 | 0.040 |
Why?
| | Maternal Health | 1 | 2019 | 50 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 572 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 2020 | 189 | 0.040 |
Why?
| | Internship and Residency | 2 | 2020 | 1267 | 0.040 |
Why?
| | Tissue Engineering | 1 | 2023 | 439 | 0.040 |
Why?
| | Schools, Medical | 1 | 2020 | 159 | 0.040 |
Why?
| | Contrast Media | 1 | 2022 | 497 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 628 | 0.030 |
Why?
| | GAP-43 Protein | 1 | 2018 | 7 | 0.030 |
Why?
| | Intermediate Filaments | 1 | 2018 | 25 | 0.030 |
Why?
| | Axons | 1 | 2020 | 204 | 0.030 |
Why?
| | Tensile Strength | 1 | 2018 | 98 | 0.030 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 79 | 0.030 |
Why?
| | Elastomers | 1 | 2017 | 30 | 0.030 |
Why?
| | Polyesters | 1 | 2017 | 75 | 0.030 |
Why?
| | Needs Assessment | 1 | 2019 | 402 | 0.030 |
Why?
| | Mice | 2 | 2024 | 18329 | 0.030 |
Why?
| | Faculty, Medical | 1 | 2020 | 303 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 192 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1505 | 0.030 |
Why?
| | Apoptosis | 1 | 2024 | 2440 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 226 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 899 | 0.030 |
Why?
| | Collagen | 1 | 2018 | 457 | 0.030 |
Why?
| | Wound Healing | 1 | 2018 | 355 | 0.030 |
Why?
| | Back | 1 | 2014 | 12 | 0.030 |
Why?
| | Tissue Expansion | 1 | 2014 | 10 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 11772 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 7123 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2017 | 381 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 2018 | 429 | 0.030 |
Why?
| | Pulse Therapy, Drug | 1 | 2013 | 7 | 0.020 |
Why?
| | Fetus | 1 | 2018 | 804 | 0.020 |
Why?
| | Child | 2 | 2014 | 22707 | 0.020 |
Why?
| | Gene Expression | 1 | 2018 | 1476 | 0.020 |
Why?
| | Neural Conduction | 1 | 2013 | 92 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2013 | 62 | 0.020 |
Why?
| | Muscular Atrophy | 1 | 2013 | 87 | 0.020 |
Why?
| | Locomotion | 1 | 2013 | 101 | 0.020 |
Why?
| | United States | 2 | 2020 | 16098 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 1193 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 365 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 1036 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2009 | 58 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 477 | 0.020 |
Why?
| | Rats, Inbred WF | 1 | 2009 | 8 | 0.020 |
Why?
| | Antilymphocyte Serum | 1 | 2009 | 57 | 0.020 |
Why?
| | Femoral Vein | 1 | 2009 | 38 | 0.020 |
Why?
| | Administration, Topical | 1 | 2009 | 153 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2009 | 162 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5904 | 0.020 |
Why?
| | Femoral Artery | 1 | 2009 | 190 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 7202 | 0.020 |
Why?
| | Female | 3 | 2020 | 78844 | 0.010 |
Why?
| | Risk Factors | 1 | 2019 | 10885 | 0.010 |
Why?
| | Skin | 1 | 2009 | 753 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 6013 | 0.010 |
Why?
| | Adult | 2 | 2019 | 40777 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2970 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14218 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 17291 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 22529 | 0.010 |
Why?
|
|
Washington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|